Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Martins-Branco D, Kassapian M, Debien V, Caparica R, et al. The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study. Breast Cancer Res Treat 2023 Nov 8. doi: 10.1007/s10549-023-07159.
PMID: 37938495


Privacy Policy